Screener
Biogen BIIB Other income, net
Other income, net at other companies
Other financials
Where this comes from
Reported directly by Biogen in its filing.
Tagged under the XBRL concept us-gaap:OtherOperatingIncomeExpenseNet.
The source filing: Biogen’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 6:36 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000875045-26-000075
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Collaboration profit sharing/(loss reimbursement) | 68.8 | 75.0 | 143.0 | 133.1 |
| (Gain) loss on fair value remeasurement of contingent consideration | 2.5 | 13.2 | 23.0 | 22.8 |
| Restructuring charges | 165.4 | (0.7) | 173.3 | 34.6 |
| Other (income) expense, net | 18.5 | 48.7 | 38.2 | 117.1 |
| Total cost and expense | 2,603.6 | 1,901.5 | 4,703.7 | 4,021.3 |
| Income before income tax (benefit) expense | 132.4 | 744.0 | 510.1 | 1,055.2 |
| Income tax (benefit) expense | 34.9 | 109.2 | 93.1 | 179.9 |
| Net income attributable to Biogen Inc. | $97.5 | $634.8 | $417.0 | $875.3 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Biogen's other income, net?
- Biogen (BIIB) reported other income, net of -$18.5M in Q2 2026.
- How has Biogen's other income, net changed year-over-year?
- Biogen's other income, net increased by 62.0% year-over-year, from -$48.7M to -$18.5M.
Ask your AI about Biogen's other income, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude